Changes in clinical condition and quality of life of patients with involutional changes of facial skin and metabolic syndrome after the course of treatment with therapeutic physical factors

封面

如何引用文章

全文:

开放存取 开放存取
受限制的访问 ##reader.subscriptionAccessGranted##
受限制的访问 订阅存取

详细

BACKGROUND: The presence of concomitant chronic non-infectious diseases, which significantly increase in probability and severity with age, contributes to the intensity of external manifestations of involutional processes. This is absolutely true for the metabolic syndrome, which is confirmed to be associated with involutional changes in the skin and soft tissues of the face through systemic mechanisms of comorbidity, determining mutual additive influences.

AIM: The aim of the study was to evaluate the clinical efficacy of the combined use of transcranial magnetic field therapy, oxygen bar therapy, and laser phoresis of hyaluronic acid for the treatment of involutional skin changes in patients with metabolic syndrome.

MATERIALS AND METHODS: Using a simple randomization technique, patients with involutional skin changes associated with metabolic syndrome (n=120) were divided into 4 groups of 30 subjects each. Subjects in group 1 (control group) received only laser phoresis of hyaluronic acid; subjects in group 2 (comparator group 1) received one course of transcranial magnetic therapy; subjects in group 3 (comparator group 2) received one course of oxygen bar therapy; subjects in group 4 (experimental group) received one course of combined treatment (laser phoresis of hyaluronic acid + transcranial magnetic therapy + oxygen bar therapy). Results were evaluated based on changes in the severity of key clinical and functional signs of age-related skin changes. In addition, the quality of life of the patients was evaluated using the Dermatologic Index, and the overall aesthetic improvement was evaluated using the Global Aesthetic Improvement Scale (GAIS).

RESULTS: The comorbidity of chronoaging with metabolic syndrome is associated with subjectively more severe major clinical manifestations of facial skin aging and indicative changes in its morphological and functional parameters. A comparative analysis of the effectiveness of using different monotherapy regimens showed the most significant regression of clinical manifestations with the laser phoresis of hyaluronic acid. The total subjective score of major clinical manifestations of age-related skin changes decreased by 39.8% on a visual analog scale (VAS), and the quality of life increased by 61.7%. The GAIS score was 2.48. Visual analog scale scores were largely consistent with changes in objective skin parameters. In the transcranial magnetic therapy and oxygen bar therapy groups, the effect was weaker and almost equal. The highest efficacy was reported in the experimental group: regression of clinical manifestations of skin chronoaging and restoration of objective dermal parameters were reliable and exceeded the level of the control group after the treatment.

CONCLUSION: The combined treatment shows a significant increase in clinical efficacy due to the pathogenetic effect on the metabolic syndrome. Sinergy of therapeutic physical factors is achieved by different modalities, sites of treatment, and mechanisms of biological potential.

作者简介

Alexey Danilov

Love Clinic

Email: xlg@inbox.ru
ORCID iD: 0009-0001-3272-2521
SPIN 代码: 8671-1713

MD

俄罗斯联邦, Moscow

Anna Mikhailova

Petrovsky National Research Centre of Surgery

Email: noc@med.ru
ORCID iD: 0000-0002-4260-1619
SPIN 代码: 7673-3241

MD, Dr. Sci. (Medicine), Associate Professor

俄罗斯联邦, Moscow

Valery Frolkov

Petrovsky National Research Centre of Surgery

Email: fvk49@mail.ru
ORCID iD: 0000-0002-1277-5183
SPIN 代码: 3183-0883

Dr. Sci. (Biological), Professor

俄罗斯联邦, Moscow

Sergey Nagornev

Petrovsky National Research Centre of Surgery

编辑信件的主要联系方式.
Email: drnag@mail.ru
ORCID iD: 0000-0002-1190-1440
SPIN 代码: 2099-3854

MD, Dr. Sci. (Medicine), Professor

俄罗斯联邦, Moscow

参考

  1. Ayvazyan TA, Alexandrova IE, Anufrieva EV, et al. Health of a healthy person. 3rd ed., revised and updated. Moscow: International University of Regenerative Medicine; 2016. 624 р. (In Russ.)
  2. Blokzijl F, de Ligt J, Jager M, et al. Tissue-specific mutation accumulation in human adult stem cells during life. Nature. 2016;538(7624):260–264. EDN: XULDOD doi: 10.1038/nature19768
  3. Reilly MJ, Tomsic JA, Fernandez SJ, Davison SP. Effect of facial rejuvenation surgery on perceived attractiveness, femininity, and personality. JAMA Facial Plast Surg. 2015;17(3):202–207. doi: 10.1001/jamafacial.2015.0158
  4. Swift A, Liew S, Weinkle S, et al. The facial aging process from the “inside out”. Aesthet Surg J. 2021;41(10):1107–1119. doi: 10.1093/asj/sjaa339
  5. Kotenko KV, Eremin II, Moroz BB, et al. CELL Technologies in the treatment of radiation burns: Experience Burnasyan federal medical biophysical centre. Kletochnaya transplantologiya i tkanevaya inzheneriya. 2012;7(2):97–102. EDN: PATDYX
  6. Zhang S, Duan E. Fighting against skin aging: The way from bench to bedside. Cell Transplant. 2018;27(5):729–738. doi: 10.1177/0963689717725755
  7. Gerth DJ. Structural and volumetric changes in the aging face. Facial Plast Surg. 2015;31(1):3–9. EDN: SNBMZS doi: 10.1055/s-0035-1544252
  8. Khetpal S, Ghosh D, Roostaeian J. Innovations in skin and soft tissue aging: A systematic literature review and market analysis of therapeutics and associated outcomes. Aesthetic Plast Surg. 2023;47(4):1609–1622. EDN: JIMTQK doi: 10.1007/s00266-023-03322-1
  9. Tarasova OV. Comparative evaluation of the effectiveness of laser technologies in the correction of involutional changes of facial skin in patients with diabetes mellitus [dissertation abstract]: 14.03.11. Place of defence: Central State Medical Academy of the Administration of Affairs of the President of the Russian Federation. Moscow; 2019. (In Russ.)
  10. Danilov AA, Mikhailova AA, Edelev DA, Tyan VV. Involutive skin changes in the background metabolic syndrome ― prerequisites for the development of complex physiotherapeutic influence (part 1). Russ J Environmental Rehab Med. 2023;(3):52–59. EDN: MKWLYR
  11. Danilov AA, Mikhailova AA, Edelev DA, Tyan VV. Involutive skin changes in the background metabolic syndrome ― prerequisites for the development of complex physiotherapeutic influence (part 2). Russ J Environmental Rehab Med. 2023;(4):40–47. EDN: BLTJKZ
  12. Nizamutdinova R, Khasanova RY, Sagitova RR, et al. Metabolic syndrome as a risk factor for premature aging. In: Actual issues of human ecology: A collection of scientific articles of participants of the All-Russian scientific and practical conference with international participation: in 3 volumes. Vol. 2. Ufa: Research Centre for Information and Legal Technologies; 2015. Р. 100–105.
  13. Glagoleva EN, Sidorov VV, Podoplekina ND, Faizullina DR. Evaluation of microcirculatory tissue systems after cosmetic procedures. Regional Blood Circulation Microcirculation. 2020;19(3):25–30. EDN: BAUZQW doi: 10.24884/1682-6655-2020-19-3-25-30
  14. Protasoni M, Serrano M. Targeting mitochondria to control ageing and senescence. Pharmaceutics. 2023;15(2):352. EDN: OYQVOW doi: 10.3390/pharmaceutics15020352
  15. Klemo V, Perišić MM, Štorga M, et al. Epigenetics insights from perceived facial aging. Clin Epigenetics. 2023;15(1):176. EDN: XTJHLD doi: 10.1186/s13148-023-01590-x
  16. Hajam YA, Rani R, Ganie SY, et al. Oxidative stress in human pathology and aging: Molecular mechanisms and perspectives. Cells. 2022;11(3):552. EDN: CJVEAV doi: 10.3390/cells11030552
  17. Chen B, Yang J, Song Y, et al. Skin immunosenescence and type 2 inflammation: A mini-review with an inflammaging perspective. Front Cell Dev Biol. 2022;10:835675. EDN: USNHJO doi: 10.3389/fcell.2022.835675
  18. Unnikrishnan A, Freeman WM, Jackson J, et al. The role of DNA methylation in epigenetics of aging. Pharmacol Ther. 2019;195:172–185.
  19. Kolesnichenko PL. Life safety: textbook. Moscow: GEOTAR-Media; 2017. 544 р. (In Russ.)
  20. Alenichev AY, Bragina IY, Bochkova NV, Tarasova OV. Involute changes of skin: Current trends of use of physiotherapeutic technologies. Physiotherapist = Fiziotherapeutist. 2018;(4):50–57. EDN: XZDIBV
  21. Kolsanova OA, Suslin SA. Modern problems of the organization of the use of hardware in cosmetology clinics. Curr Problems Health Care Med Statist. 2023;(2):648–665. EDN: YUBYMU doi: 10.24412/2312-2935-2023-2-648-665
  22. Kruglova LS, Tarasova OV, Rzhevskaya LV. Use of laser therapy for patients with involute changes of skin against the background of a diabetes mellitus 2 types. Physiotherapist = Fiziotherapeutist. 2019;(4):30–57. EDN: EIDIJR
  23. Yusova JY. High intensity laser technology in a complex correction involutive skin changes. Physiotherapist = Fiziotherapeutist. 2015;(5):37–42. EDN: UKFKVN
  24. Yusova ZY, Baranova EL, Demidion DV, Kruglova LS. Phonophoresis with hyaluronic acid and laser technologies in correction of skin involution. Plastic Surg Aesthetic Med = Plasticheskaya Khirurgiya i Esteticheskaya Meditsina. 2023;(2):63–66. EDN: BXCEXK doi: 10.17116/plast.hirurgia202302163
  25. Demidion DV. Interference of pulsed light and high-intensity selective laser technologies in correction of involutional changes of facial skin [dissertation abstract]: 3.1.33. Place of defence: Tsentral’naya gosudarstvennaya meditsinskaya akademiya. Moscow; 2023. 151 р. (In Russ.)
  26. Recommendations for the management of patients with metabolic syndrome. Clinical Recommendations. Moscow; 2013. 43 р. (In Russ.)
  27. Moskvin SV, Geinitz AV, Khazov MB, et al. Laser phoresis of hyaluronic acid and laser cosmetology programmes (LASMIC technology). Moscow-Tver: Triada; 2010. 96 р. (In Russ.)
  28. Uiba VV, Kotenko KV, Kolbakhova SN. The latest technologies of restorative medicine for the treatment of occupational lung diseases. In: The First All-Russian Congress of Doctors of Restorative Medicine: Materials congress, 27 February–01 March. Moscow; 2007. 282 p. (In Russ.) EDN: QBOLBV
  29. Evans M, Lewis ED, Zakaria N, et al. A randomized, triple-blind, placebo-controlled, parallel study to evaluate the efficacy of a freshwater marine collagen on skin wrinkles and elasticity. J Cosmet Dermatol. 2021;20(3):825–834. EDN: XMDCGF doi: 10.1111/jocd.13676
  30. Draelos ZD, Diaz I. The benefits of a multimechanistic antiaging skin technology. Dermatol Ther (Heidelb). 2023;13(12):3111–3119. EDN: KFPAXA doi: 10.1007/s13555-023-01055-2
  31. Rattanawiwatpong P, Wanitphakdeedecha R, Bumrungpert A, et al. Anti-aging and brightening effects of a topical treatment containing vitamin C, vitamin E, and raspberry leaf cell culture extract: A split-face, randomized controlled trial. J Cosmet Dermatol. 2020;19(3):671–676. doi: 10.1111/jocd.13305
  32. Zakirova GS, Gubanova EI, Gladko VV, et al. A randomized study of the safety and effectiveness of products based on stabilized hyaluronic acid for the correction of involutional changes in face and neck. Russ J Skin Venereal Dis = Rossiiskii zhurnal kozhnykh i venericheskikh boleznei. 2018;21(1):53–60. EDN: XTCGRF doi: 10.18821/1560-9588-2018-21-1-51-53-60
  33. Gfrerer L, Kilmer SL, Waibel JS, et al. Dermal micro-coring for the treatment of moderate to severe facial wrinkles. Plast Reconstr Surg Glob Open. 2022;10(10):e4547. EDN: GHHPIH doi: 10.1097/GOX.0000000000004547
  34. Al-Otaibi HM, Al-Furayh NA, Al-Nooh BM, et al. Quality of life assessment among patients suffering from different dermatological diseases. Saudi Med J. 2021;42(11):1195–1200. EDN: BRBNEF doi: 10.15537/smj.2021.42.11.20210560
  35. Băbțan AM, Vesa ȘC, Boșca BA, et al. High-frequency ultrasound assessment of skin and oral mucosa in metabolic syndrome patients: A cross-sectional study. J Clin Med. 2021;10(19):4461. EDN: PYETTI doi: 10.3390/jcm10194461
  36. Ruiz-Esparza GU, Flores-Arredondo JH, Segura-Ibarra V, et al. The physiology of cardiovascular disease and innovative liposomal platforms for therapy. Int J Nanomedicine. 2013;8:629–640. doi: 10.2147/IJN.S30599
  37. Papaccio F, D’Arino A, Caputo S, et al. Focus on the contribution of oxidative stress in skin aging. Antioxidants (Basel). 2022;11(6):1121. EDN: LPMXBD doi: 10.3390/antiox11061121
  38. Gill V, Kumar V, Singh K, et al. Advanced glycation end products (AGEs) may be a striking link between modern diet and health. Biomolecules. 2019;9(12):888. doi: 10.3390/biom9120888
  39. Băbţan AM, Boşca BA, Petrescu NB, et al. Accumulation of N-epsilon carboxymethyl lysine in various tissues and organs related to diet-induced aging process. State of the art and experimental animal study. Human Veterinary Medicine. 2019;11(3):106–115.
  40. Sreedhar A, Aguilera-Aguirre L, Singh KK. Mitochondria in skin health, aging, and disease. Cell Death Dis. 2020;11(6):444. EDN: VKPPTY doi: 10.1038/s41419-020-2649-z
  41. Prahl S, Kueper T, Biernoth T, et al. Aging skin is functionally anaerobic: Importance of coenzyme Q10 for antiaging skin care. Biofactors. 2008;32(1-4):245–255. doi: 10.1002/biof.5520320129
  42. Bowman A, Birch-Machin MA. Age-dependent decrease of mitochondrial complex II activity in human skin fibroblasts. J Invest Dermatol. 2016;136(5):912–919. doi: 10.1016/j.jid.2016.01.017
  43. Passos JF, Zglinicki T. Mitochondrial dysfunction and cell senescence-skin deep into mammalian aging. Aging (Albany NY). 2012;4(2):74–75. doi: 10.18632/aging.100432
  44. Feichtinger RG, Sperl W, Bauer JW, et al. Mitochondrial dysfunction: A neglected component of skin diseases. Exp Dermatol. 2014;23(9):607–614. doi: 10.1111/exd.12484
  45. Hussain M, Krishnamurthy S, Patel J, et al. Skin abnormalities in disorders with DNA repair defects, premature aging, and mitochondrial dysfunction. J Invest Dermatol. 2021;141(4S):968–975. EDN: STJNLK doi: 10.1016/j.jid.2020.10.019
  46. Wang Z, Wang Y, Bradbury N, et al. Skin wound closure delay in metabolic syndrome correlates with SCF deficiency in keratinocytes. Sci Rep. 2020;10(1):21732. EDN: UYCSIV doi: 10.1038/s41598-020-78244-y
  47. Imaeva NA, Potekaev NN, Tkachenko SB, Shuginina EA. Microcirculation disturbances in various skin ageing types. Cardiovascular Therapy Prevention. 2008;7(3):107–110. EDN: IJULDX
  48. Bentov I, Reed MJ. The effect of aging on the cutaneous microvasculature. Microvasc Res. 2015;100:25–31 doi: 10.1016/j.mvr.2015.04.004
  49. Feher A, Broskova Z, Bagi Z. Age-related impairment of conducted dilation in human coronary arterioles. Am J Physiol Heart Circ Physiol. 2014;306(12):H1595–1601. doi: 10.1152/ajpheart.00179.2014
  50. Efimov AA, Savenkova EN, Alekseev YD. Analysis of synchronism age changes of elastic properties of big arteries and human skin. Sovremennye problemy nauki i obrazovaniya. 2013;(3):125. EDN: RPOKFX
  51. Kulchitskaya DB, Fesyun AD, Yusova ZY, et al. Endothelium functional activity in different morphotypes of facial skin aging. Russ J Clin Dermatol Venereol. 2022;21(2):238–241. EDN: SOQXTB doi: 10.17116/klinderma202221021238
  52. Papakonstantinou E, Roth M, Karakiulakis G. Hyaluronic acid: A key molecule in skin aging. Dermatoendocrinol. 2012;4(3):253–258. doi: 10.4161/derm.21923
  53. Vasvani S, Kulkarni P, Rawtani D. Hyaluronic acid: A review on its biology, aspects of drug delivery, route of administrations and a special emphasis on its approved marketed products and recent clinical studies. Int J Biol Macromol. 2020;151:1012–1029. EDN: PZBGFS doi: 10.1016/j.ijbiomac.2019.11.066
  54. Bravo B, Correia P, Gonçalves JE, et al. Benefits of topical hyaluronic acid for skin quality and signs of skin aging: From literature review to clinical evidence. Dermatol Ther. 2022;35(12):e15903. EDN: HFVRIH doi: 10.1111/dth.15903
  55. Konchugova TV. Laser phoresis ― development prospects of the method (brief literature report). Vestnik novyh medicinskih tehnologii. 2016;(3): 289–295. EDN: WLSLON
  56. Uiba VV, Kotenko V, Korchazhkina NB, Babyakin AF. Natural and preformed physical factors in resort treatment of arthrosis of large joints. Training manual. Vol. 1. Pyatigorsk; 2011. 20 р. (In Russ.) EDN: PXDXGT.
  57. Moskvin SV. Efficiency of laser therapy. Vol. 2. Moscow-Tver: Triada; 2014. 896 р. (In Russ.)
  58. Ulashchik VS. Combined physical therapy: General information, interaction between physical factors. Voprosy kurortologii, fizioterapii i lechebnoi fizicheskoi kultury = Problems Balneol Physiother Exercise Ther. 2016;(6):4–11. EDN: XHUGKX doi: 10.17116/kurort201664-11

补充文件

附件文件
动作
1. JATS XML
下载

版权所有 © Eco-Vector, 2024

Creative Commons License
此作品已接受知识共享署名-非商业性使用-禁止演绎 4.0国际许可协议的许可。
 


Согласие на обработку персональных данных с помощью сервиса «Яндекс.Метрика»

1. Я (далее – «Пользователь» или «Субъект персональных данных»), осуществляя использование сайта https://journals.rcsi.science/ (далее – «Сайт»), подтверждая свою полную дееспособность даю согласие на обработку персональных данных с использованием средств автоматизации Оператору - федеральному государственному бюджетному учреждению «Российский центр научной информации» (РЦНИ), далее – «Оператор», расположенному по адресу: 119991, г. Москва, Ленинский просп., д.32А, со следующими условиями.

2. Категории обрабатываемых данных: файлы «cookies» (куки-файлы). Файлы «cookie» – это небольшой текстовый файл, который веб-сервер может хранить в браузере Пользователя. Данные файлы веб-сервер загружает на устройство Пользователя при посещении им Сайта. При каждом следующем посещении Пользователем Сайта «cookie» файлы отправляются на Сайт Оператора. Данные файлы позволяют Сайту распознавать устройство Пользователя. Содержимое такого файла может как относиться, так и не относиться к персональным данным, в зависимости от того, содержит ли такой файл персональные данные или содержит обезличенные технические данные.

3. Цель обработки персональных данных: анализ пользовательской активности с помощью сервиса «Яндекс.Метрика».

4. Категории субъектов персональных данных: все Пользователи Сайта, которые дали согласие на обработку файлов «cookie».

5. Способы обработки: сбор, запись, систематизация, накопление, хранение, уточнение (обновление, изменение), извлечение, использование, передача (доступ, предоставление), блокирование, удаление, уничтожение персональных данных.

6. Срок обработки и хранения: до получения от Субъекта персональных данных требования о прекращении обработки/отзыва согласия.

7. Способ отзыва: заявление об отзыве в письменном виде путём его направления на адрес электронной почты Оператора: info@rcsi.science или путем письменного обращения по юридическому адресу: 119991, г. Москва, Ленинский просп., д.32А

8. Субъект персональных данных вправе запретить своему оборудованию прием этих данных или ограничить прием этих данных. При отказе от получения таких данных или при ограничении приема данных некоторые функции Сайта могут работать некорректно. Субъект персональных данных обязуется сам настроить свое оборудование таким способом, чтобы оно обеспечивало адекватный его желаниям режим работы и уровень защиты данных файлов «cookie», Оператор не предоставляет технологических и правовых консультаций на темы подобного характера.

9. Порядок уничтожения персональных данных при достижении цели их обработки или при наступлении иных законных оснований определяется Оператором в соответствии с законодательством Российской Федерации.

10. Я согласен/согласна квалифицировать в качестве своей простой электронной подписи под настоящим Согласием и под Политикой обработки персональных данных выполнение мною следующего действия на сайте: https://journals.rcsi.science/ нажатие мною на интерфейсе с текстом: «Сайт использует сервис «Яндекс.Метрика» (который использует файлы «cookie») на элемент с текстом «Принять и продолжить».